Compare Elevance Health Inc. Common Stock (ELV) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Elevance Health Inc. Common Stock vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Elevance Health Inc. Common Stock trades at $401.8 (market cap $86.95B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.37 (market cap $2.27B). The key difference: Elevance Health Inc. Common Stock is far larger — about 38.3× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Elevance Health Inc. Common Stock pays a 1.72% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| ELV | SLS | |
|---|---|---|
Market Cap | $86.95B | $2.27B |
Volume | 782,706 | 4,179,659 |
Sector | Health | Health |
52-Week High | $426.79 | $15.46 |
52-Week Low | $280.74 | $1.39 |
Enterprise Value | $107.76B | $2.14B |
Dividend Yield | 1.72% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Elevance Health Inc. Common Stock
Elevance Health provides health plans and healthcare services. Its offerings include medical, behavioral health, pharmacy, dental, vision, and complex-care solutions, including through the Carelon business.
Read more on ELV →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
